Background
==========

Hypertension is a major and common risk factor for premature disability and death \[[@B1]-[@B3]\]. It is a leading cause of stroke, congestive heart failure, and other cardiovascular diseases in Western \[[@B4]-[@B6]\] and Asian \[[@B7]\] populations. Its control is necessary for the prevention of related adverse effects \[[@B8]\]. Some studies have shown poor awareness and control of hypertension in different populations including Iranian populations. This undesirable level of hypertension control may provide a promising area for aggressive intervention \[[@B9]\].

Previous studies in Iranian population showed that despite improvement in the awareness, treatment and control rate of hypertension the situation is not desirable\[[@B9],[@B10]\]. As a public health response to the escalating trend of chronic non-communicable diseases (NCDs) in Iran, Isfahan Healthy Heart Program (IHHP) was conducted as a comprehensive healthy lifestyle community trial for NCDs prevention and health promotion \[[@B10],[@B11]\]. Its interventions were conducted in two provincial counties of Isfahan and Najaf-Abad and were compared with Arak as reference area. One of the objectives of this program was to increase the awareness, treatment and control rates of hypertension \[[@B11]\].

Given the awareness, treatment and control rates of hypertension are low in Iranians \[[@B9]\] it seems that low community awareness and lack of physician training are important. Therefore, IHHP aimed to increase the awareness rate of community and to improve the level of treatment among hypertensive individuals. Increasing the level of health professional\'s knowledge and treatment skills about hypertension were another goals in this program. This paper presents the results of the 6-years interventions of IHHP on the prevalence of hypertension as well as the changes of hypertension awareness, treatment, and control in the population of the interventional areas in comparison with the reference area. It also reports these differences based on area of residence, age groups and body mass index (BMI).

Methods
=======

IHHP was conducted as a community-based program for promoting healthy lifestyle behaviors, and ultimately to prevent NCDs in a developing country setting. It integrates interventions and policies that target the major determinants of NCDs including unhealthy nutrition, smoking, physical inactivity and stress \[[@B10],[@B11]\]. Ethics committee of Isfahan Cardiovascular Research Center, a collaborating center of the World Health Organization, and affiliated to Isfahan University of Medical Sciences and other relevant national regulatory organizations approved this study. Written informed consent was obtained from participants after full explanation of the study protocol. In 2000-2001, the baseline survey was conducted in three counties. Two provincial counties of Isfahan and Najaf-Abad with populations of 1,895,856 and 275,084, respectively, were considered as venues of intervention; and Arak, a provincial county located 375 km northwest of Isfahan with a population of 668,531, as the reference area because of socioeconomic, demographic, health profile similarities to the intervention areas. The populations of the three counties were studied for cardiovascular disease (CVD) related risk behaviors and risk factors.

After the baseline survey in 2000, from 2001 interventions were conducted in the intervention communities, and Arak was monitored for comparative purposes; routine national health activities were continuing in both intervention and reference areas. IHHP was developed as an action-oriented, quasi-experimental demonstration program with simultaneous evaluation and different research studies. Its interventions were conducted through 10 projects with different target groups (Additional file [1](#S1){ref-type="supplementary-material"}). Behavioral variables were determined through annual questionnaire-based surveys on independent samples in intervention and reference communities. Then, in 2007 the whole baseline survey was repeated on an independent random sample of both communities. Individuals were selected using multistage random sampling and were invited to the survey centers for interview, clinical examination and blood sampling. A standardized questionnaire was used to obtain information on demographic and socioeconomic aspects.

A trained team of physicians performed physical examinations using standardized and zero-calibrated instruments for measuring blood pressure(BP) \[[@B12]\]. BP was measured, manually by a trained operator using a mercury sphygmomanometer according to a standard protocol, twice from each right and left arms in sitting position after 5 minutes of rest. The first Korotkoff sound was recorded as the systolic blood pressure (SBP) and the disappearance of the sounds (V phase) was considered as the diastolic blood Pressure (DBP). The values of hypertension used in analysis were recorded as mean measured BP in higher arm \[[@B13]\].

The aims of our interventions are to improve the knowledge, attitude and behaviors of general population, hypertensive patients, their relatives and health professionals and to increase the chance of early detection, treatment and control of hypertension by means of education of health professionals (physicians, nurses and health staff), patients and public about prevention, early diagnosis, adherence to treatment and control of hypertension.

Hypertension was defined as an average BP equal or more than 140/90 mm Hg in non-diabetic patients and equal or more than 130/80 mmHg in diabetic subjects\[[@B12]\] or if the patient was taking antihypertensive medications. Participants, who had been previously diagnosed to have hypertension, were considered to be aware of their hypertension. Participants were considered to be treated if they were taking antihypertensive drugs. Hypertension was considered controlled if the patients were receiving anti-hypertensive medications and their average blood pressure was considered less than 140/90 mm Hg in non-diabetic patients or less than 130/80 mmHg in diabetic patients. Participants were considered to have diabetes whether it had been diagnosed previously by a doctor or they had two separate fasting blood glucose more than 125 mg/dl or 2 hour post-prandial glucose more than 200 mg/dl or if they were receiving anti-diabetic medications \[[@B13]\].

For quality control purposes, the whole IHHP have been extremely evaluated with promising results \[[@B11]\].

Statistical analysis
--------------------

Statistical analysis was performed using the SPSS statistical package version 15.0 for Windows (SPSS Inc., Chicago, USA). The significance level was set at P \< 0.05. The data are presented as frequencies, percentages and 95% confidence intervals. Prevalence of hypertension, awareness, treatment, and control rates in interventional and reference areas were compared by x² test. The prevalence of hypertension as well as the awareness, treatment, and control rates were adjusted for age, sex and BMI were compared with logistic regression test to calculate the independent association between the above variables and the prevalence, awareness, treatment and control rates of hypertension.

Results
=======

In this study, data on 10884 participants in interventional counties (Isfahan and Najaf Abad) and 11192 in reference city (Arak) were included in 2001 and 2007 as a whole. The study population of the pre-intervention survey included 6175 in the interventional area and 6339 in the reference area. The corresponding figure in the post-intervention survey was 4717 (47.19% male) in the interventional area and 4853 (50.7% male) individuals in the reference area.

Table [1](#T1){ref-type="table"} shows the age, sex, BMI, BP and diabetes status of the population studied in 2001 and 2007. There was no overall significant difference in mean age in interventional and reference Table [2](#T2){ref-type="table"} demonstrates the prevalence, awareness, treatment and control of hypertension in interventional vs. reference areas in 2001 and 2007. The prevalence of hypertension in the interventional areas had a non-significant decrease from 20.5% in 2001 to 19.6% in 2007, whereas in the reference area, it had a significant rise from 17.4% to 19.6% (P = 0.003) respectively. If we consider blood pressure≥ 140/90 in diabetic and non diabetic individuals for definition of hypertension the prevalence of hypertension in the interventional had no significant decrease from 18.9% in 2001 to 17.8 in 2007, whereas in the reference area, it had a significant rise from 15.7% to 17.9%(p = 0.002). Mean systolic blood pressure in study population decreased significantly in interventional area (P \< 0.001) whereas in the reference population, this decline was not significant (P = 0.24). Mean diastolic blood pressure decreased in both interventional and reference areas but this reduction was significant in reference area.

###### 

Characteristics of participants: IHHP program

  ----------------------------------------------------------------------------------------------------------------------------------------
                                      Interventional area   reference area                                                         
  ----------------------------------- --------------------- ---------------- --------- ---------------- ---------------- --------- -------
  **Age year (mean±SD)**              38.61 ± 14.72         38.54 ± 15.27    0.83      39.17 ± 15.12    39.03 ± 15.85    0.64      

  **Sex**                             **Male**              48.7%            49.3%                      49.2%            50.7%     

                                      **Female**            51.3%            50.7%     0.51             50.8%            49.3%     0.12

  **BMI (kg/m^1)^**                   **\<25**              45.7%            44.5%                      53.1%            49.4%     

                                      **25-\<29.9**         35.4%            37.0%     0.23             32.6%            34.9%     0.001

                                      **30**                18.9%            18.5%                      14.3%            15.6%     

  **Diabetes mellitus**               6.3%                  7.1%             0.09      4.9%             6.5%             \<0.001   

  **Prevalence of hypertension**\     20.5%                 19.6%            0.24      17.4%            19.6%            0.003     
  **base on DM(2)**                                                                                                                

  **Prevalence of hypertension(3)**   18.9%                 17.8%            0.14      15.7%            17.9%            0.002     

  **Mean systolic blood pressure**    116.13 ± 19.37        112.92 ± 18.27   \<0.001   115.22 ± 18.96   114.79 ± 19.62   0.24      

  **Mean diastolic blood pressure**   74.79 ± 11.93         74.43 ± 11.06    0.11      76.18 ± 10.22    73.54 ± 11.03    \<0.001   
  ----------------------------------------------------------------------------------------------------------------------------------------

1\) Body mass index (kg/m2)

2\) BP ≥ 140/90 in nondiabetic BP ≥ 130/90 in diabetic patient

3\) BP ≥ 140/90 in diabetic & nondiabetic patient

###### 

Awareness, treatment and control rates of hypertension in interventional and reference area: IHHP, 2001-2007

  --------------------------------------------------------------------------------------------------------------------------------------
  Time Area             Awareness   Treatment   Control                                                                        
  --------------------- ----------- ----------- ----------- --------- ----------- ----------- --------- ---------- ----------- ---------
  Interventional area   Urban       404(41.6)   349(48)     0.009     341(35.2)   305(42.5)   0.002     77(7.9)    112(15.6)   \<0.001

                                                                                                                               

                        Rural       107(36.5)   92(58.2)    \<0.001   100(34.2)   78(49.7)    0.001     12(4.1)    26(16.6)    \<0.001

                                                                                                                               

                        Total       511(40.4)   441(49.8)   \<0.001   441(34.9)   383(43.8)   \<0.001   89(7.1)    138(15.8)   \<0.001

                                                                                                                               

  Reference\            Urban       314(44.1)   212(48.5)   0.15      267(37.5)   190(43.8)   0.035     78(11)     71(16.4)    0.009
  Area                                                                                                                         

                                                                                                                               

                        Rural       143(37.1)   232(45.2)   0.015     121(31.5)   188(36.9)   0.096     29(7.6)    61(12)      0.031

                                                                                                                               

                        Total       457(41.7)   444(46.7)   0.021     388(35.4)   378(40)     0.031     107(9.8)   132(14)     0.003
  --------------------------------------------------------------------------------------------------------------------------------------

The awareness, treatment and control of hypertension increased significantly in rural and urban areas of interventional countries (P \< 0.001), the awareness and treatment were not significant in the reference area. (Table [2](#T2){ref-type="table"})

Table [3](#T3){ref-type="table"} shows that in interventional areas, the awareness, treatment, and control rates of hypertension increased significantly in the age groups of more than 40 years (*P \<*0.01). In the age group of 19-39 years old no significant increase was seen in the awareness, treatment, and control rates of hypertension. This table also shows that the awareness, treatment and control rates of hypertension had a more favorable improvement in interventional than in reference area. These rates had significant improvement in population aged ≥40 years in interventional vs. reference areas too. Awareness, treatment and control rates of hypertension increased significantly in all groups of BMI in interventional area the corresponding figures were not significant in the reference area.

###### 

Awareness, treatment, and control of hypertension by age and body mass index in interventional and reference areas: IHHP, 2001-2007

  ------------------------------------------------------------------------------------------------------------------------------------------
                          Percentage (%)                                                                                   
  ----------------------- ------------------------- -------------------- ----------------- --------------- --------------- -----------------
  **Age and BMI**         **Interventional area**   **Reference area**                                                     

                          ****2001****\             ****2007****\        ****P-value****   ****2001****\   ****2007****\   ****P-value****
                          **N = 12514**             **N = 9572**                           **N = 12514**   **N = 9572**    

                                                                                                                           

  Awareness                                                                                                                

  Age, y                                                                                                                   

  19-39                   47(18.0)                  43(24.4)             0.10              26(13.1)        39(20.9)        0.043

  40-59                   206(37.9)                 183(48.8)            0.001             183(39.8)       140(41.7)       0.59

  ≥60                     258(56.2)                 215(64.4)            0.021             248(56.5)       265(62.1)       0.095

  BMI, kg/m2                                                                                                               

  \<25                    93(29.2)                  76(41.1)             0.007             146(38.3)       138(43.0)       0.209

  25-29.9                 216(40.8)                 192(49.2)            0.011             180(41.8)       191(47.9)       0.077

  ≥30                     192(48.6)                 163(56.2)            0.049             130(45.9)       111(49.8)       0.39

  Treatment                                                                                                                

  Age, y                                                                                                                   

  19-39                   33(12.7)                  29(16.6)             0.26              19(9.6)         34(18.2)        0.015

  40-59                   173(31.8)                 154(42.0)            0.002             151(32.9)       115(34.3)       0.67

  ≥60                     235(51.3)                 200(60.2)            0.013             218(49.7)       229(54.3)       0.18

  BMI, kg/m2                                                                                                               

  \<25                    87(27.4)                  70(37.8)             0.014             125(32.9)       118(36.9)       0.27

  25-29.9                 188(35.6)                 161(42.1)            0.045             148(34.3)       160(40.4)       0.071

  ≥30                     156(39.5)                 142(49.5)            0.009             114(40.3)       96(43.4)        0.48

  Control (all treated)                                                                                                    

  Age, y                                                                                                                   

  19-39                   13(5.0)                   16(9.1)              0.089             11(5.6)         21(11.2)        0.044

  40-59                   30(5.5)                   56(15.3)             \<0.001           42(9.2)         44(13.1)        0.078

  ≥60                     46(10.0)                  66(19.9)             \<0.001           54(12.3)        67(15.9)        0.13

  BMI, kg/m2                                                                                                               

  \<25                    20(6.3)                   24(13.0)             0.011             41(10.8)        47(14.7)        0.12

  25-29.9                 43(8.1)                   63(16.5)             \<0.001           42(9.8)         54(13.6)        0.083

  ≥30                     24(6.1)                   46(16.0)             \<0.001           24(8.5)         31(14.0)        0.048
  ------------------------------------------------------------------------------------------------------------------------------------------

Multiple logistic regression analysis revealed that after adjustment for the residence area and the year of study, the prevalence of hypertension in the age groups of 40 to 59 years and more than 60 years were 4.64 and 18.30 times more than the age group of 19 to 39 years. In addition, the prevalence of hypertension was 1.98 and 3.14 times higher in overweight and obese individuals in comparison with normal-weight participants. In the age groups of 40 to 59 years and more than 60 years the awareness about hypertension was 2.89 and 6.99 times higher than in the age group of 19 to 39 years. Furthermore, overweight and obese individuals were 1.35 and 1.68 times more awarded of their high blood pressure than normal weight population. Multiple logistic regression analysis revealed that the treatment of hypertension in age groups of 40 to 59 years and more than 60 years were 3.15 and 7.87 times higher than in the age group of 19 to 39 years. In addition, treatment rates were 1.22 and 1.50 times higher in overweight and obese individuals than in normal weight participants. Hypertension control was 1.46 and 2.26 times higher in the age groups of 40 to 59 years and more than 60 years than the age group of 19 to 39 years. Also it showed that the prevalence, awareness, treatment, and control rate of hypertension in high school diploma patients were better than lower educated patients. Overweight individuals had the same control rate as normal weight individuals but obese individuals had low control rate (0.86%) of hypertension in comparison with normal weight individuals. The awareness, treatment and control rates of hypertension were 2.22, 2.3, and 2.37 times more in women compared to men and in educated population it is 1.11, 1.18, and 1.61 times higher than non-educated participant (Table [4](#T4){ref-type="table"}).

###### 

Multiple logistic regressions of prevalence, awareness, treatment and control of hypertension in the interventional and reference areas: IHHP, 2001-2007

  ------------------------------------------------------------------------------------------------------------------
  Predictors                          prevalence           Awareness           Treatment          Control
  ----------------------------------- -------------------- ------------------- ------------------ ------------------
  **Age**(reference: 19-39 y)         **R**                **R**               **R**              **R**

                                                                                                  

  **40-59 y**                         4.64(4.22-5.1)       2.89(2.35-3.56)     3.15(2.51-3.97)    1.46(1.06-2.01)

                                                                                                  

  **≥60 y**                           18.30(16.37-20.46)   6.99(5.62 - 8.69)   7.87 (6.21-9.98)   2.26(1.64-3.11)

                                                                                                  

  **Sex**(reference: man)\            0.995(0.92-1.08)     2.22 (1.93-2.55)    2.298(1.99-2.65)   2.37(1.89-2.96)
  **Woman**                                                                                       

                                                                                                  

  **High school diploma**             0.69(0.63 - 0.77)    1.11(0.91-1.37)     1.18(0.95-1.46)    1.61(1.19-2.18)

                                                                                                  

  **BMI**(reference : \<25 kg/m^2^)   R                    R                   R                  R

                                                                                                  

  **Overweight**, 25-29.9 kg/m^2^     1.98(1.80-2.17)      1.35(1.15-1.59)     1.22(1.03-1.45)    1.01(0.798-1.29)

                                                                                                  

  **Obese**, ≥30 kg/m^2^              3.14(2.82-3.50)      1.68(1.397-2.01)    1.497(1.24-1.80)   0.86(0.66-1.13)
  ------------------------------------------------------------------------------------------------------------------

Adjusted for years and residency (intervention area and reference area)

Discussion
==========

In this community trial, that to the best of our knowledge is the first of its kind in developing countries, the integrated and comprehensive interventions of this population-based program resulted in favorable changes in the prevalence, awareness, treatment and control of hypertension. Although the decline in the prevalence of hypertension was not significant in the intervention countries, but by considering its significant increase in the reference country while usual health care services were similarly undergoing in both areas. It can be assumed that if specific interventional programs were not performed in interventional areas, the prevalence of hypertension would have increased similar to the reference area. Moreover, the mean systolic BP declined significantly in the intervention population but not in the reference area.

Previous studies in the US have shown that the prevalence of hypertension to be 28.7%, with an increase of 3.7% from 1988 to 1991 Hypertension. The prevalence of hypertension was highest in non-Hispanic blacks (33.5%), increased with age (65.4% among those aged ≥60 years), and tended to be higher in women (30.1%) \[[@B14]\]. In another study that was conducted in the US in 2003-2004 the overall prevalence was 29.3%. When compared with 1999-2000, there was no significant increase in the overall prevalence of hypertension \[[@B15]\]. A study in China revealed that the overall prevalence of hypertension was 48.5% \[[@B7]\].

Reduction in BP can lead to a decline in the high morbidity and mortality rate in individuals with hypertension \[[@B15]\]. Therefore, in the current study, 3.18 mmHg reductions in systolic BP in interventional areas may result to a significant decline in the incidence of heart failure, stroke, myocardial infarction and other atherosclerotic events in the future \[[@B15]\]. The reason behind this decline in interventional areas might be increasing the awareness of population about hypertension and simultaneous education of health professionals on the role of pharmacological and non pharmacological treatment as well as how to treat patient with multiple anti-hypertensive drugs and efforts to increase the patients\' compliance. The synergetic and dose of interventional activities in such comprehensive program might be effective as well.

While no change was observed in interventional areas, a significant decrease was seen in mean diastolic pressure in reference area. Changes in diastolic blood pressure in the population\'s studies are difficult to explain, whereas we educated separate personnel in interventional and reference area to measure diastolic BP. it may be due to more difficult and less accurate measurement of the diastolic blood pressure based on Korotkoff sounds in the general population. Other studies showed controversial changes in diastolic pressure during different periods of the study \[[@B15],[@B16]\].

Some studies showed Prevalence of diabetes in adults worldwide was estimated to be 4.0% in 1995 and will rise to 5.4% by the year 2025\[[@B15]\]. It is higher in developed countries than in developing ones. This increase is probably due to population aging, urbanization, and increase in the prevalence of obesity and physical inactivity \[[@B16]\]. In our study the prevalence of diabetes mellitus showed a non significant uprising trend in interventional area (from 6.3% to 7.1%) and significant increase in reference area (from 4.9% to 6.5%). This increase in control group was 2 times greater than the interventional group (table [1](#T1){ref-type="table"}). Therefore, IHHP activities may have slowed down the rapid uprising trend of diabetes in interventional areas.

Using BP ≥140/90 mm Hg as a cut-off level in hypertensive people with diabetes might underestimate the prevalence of hypertension. In our study the prevalence of diabetes in general population was up to 6.3%, (table [1](#T1){ref-type="table"}) so we defined hypertension in diabetic patients equal or more than 130/80 to attain a more accurate prevalence rate \[[@B12]\]. Additionally, studies using a BP goal of \<140/90 mm Hg in hypertensive people with diabetes might overestimate BP control rates \[[@B17]\]. Therefore, in this study consistent with a previous study \[[@B17]\], different control goals (\<130/80 mm Hg) were used for those with diabetes to provide a more accurate control rate.

Two surveys in England and Canada documented that many individuals with hypertension are unaware of their disease (63% and 42% respectively), and those who are awared are often untreated (19%) or under-treated (23%)\[[@B18],[@B19]\]. In this study the improvement in awareness, treatment and control rates of hypertension in rural and urban areas of interventional areas were the same, both better than reference area. (9.7 vs. 5.1, 8.7 vs. 4.8 and 8.7 vs. 4.4 respectively)(Table [2](#T2){ref-type="table"}). This improvement may lead to decrease future cardiovascular events in our country.

Evaluation of the increase in awareness, treatment and control of hypertension in different age groups was another important way for assessing the efficacy and conduction of interventional programs and may need more aggressive intervention in low compliance age groups. The current study demonstrates that since 2001, awareness, treatment and control rates of hypertension in patients who are older than 40 years in interventional areas increased significantly (table [3](#T3){ref-type="table"}) and this might be due to their greater concern about their health status or less effectiveness of interventional activities in younger people. In spite of non-significant rise in awareness, treatment and control of hypertension in younger patients we had a favorable trend in this group; therefore more specific programs may be needed for this age group in the future. Furthermore, previous studies such as NHANES study showed that, compared with younger individuals with hypertension, older individuals with hypertension have a lower control rate despite being equally likely to be treated\[[@B20]-[@B22]\]. Other study reported that the awareness and control rates of hypertension were better in older people, whereas there was a relatively under-treatment for the case of hypertensive people of younger age \[[@B14]\]. In our study awareness, treatment and control rates of hypertension improved significantly in normal weight, over weight and obese patients; in interventional area the corresponding figures were not significant in the reference area.

In our study, in all participants (interventional and reference areas) the number of hypertensive patients with optimal weight (BMI\< 25 kg/m^2^) decreased but in the reference area the prevalence of over-weight and obesity increased from 2001 to 2007 compared to interventional area. This might be the result of the effects of interventional activities in interventional areas. This difference in shifting BMI in interventional and reference areas may be the important reason for lesser increase in the prevalence of diabetes and hypertension in interventional areas in comparison with the reference area.

Our study showed more favorable improvement in the Awareness of Hypertension in patients living in interventional than in reference area. As well as better improvement in the treatment rate of hypertension in the overweight and Control rate in the obese hypertensive patients in interventional area compared with reference area.

Many studies showed significant positive correlation between BMI and systolic or diastolic BP in the whole population \[[@B23]-[@B25]\]. In our study, the prevalence of hypertension increased by rising BMI in general population in both intervention and reference counties. Obese individuals have approximately 3 times more chance to be hypertensive than those with optimal weight patients furthermore the awareness and treatment rates in obese patients were more than those with optimal weight but the over weight and obese patients could not control their hypertension as well as normal weight participant (table [4](#T4){ref-type="table"}). This might be due to poor compliance of obese patients in pharmacological and non-pharmacological treatment.

In the National Health Interview Survey, 38% of women 65 to 74 years old reported hypertension compared with 31% of men in the same age group \[[@B17]\]. Hajjar and colleagues showed that men experienced more hypertension than women (18.1% vs. 10.1%) \[[@B14]\]. In our study the prevalence of hypertension was not significantly different in terms of gender, this finding is contrary to some other surveys in which the prevalence of hypertension has been generally higher among males than females \[[@B13]\]. In our study, awareness, treatment and control of hypertension in women were approximately 2 times greater than men and this indicated that women had more concerns about their self-care. Also our study like other study showed that the prevalence, awareness, treatment, and control rate of hypertension in educated patients is better (table [4](#T4){ref-type="table"}). The main goals of interventional activities in this study were life-style modification and increasing the awareness of the community for better detection of hypertension and encouragement of hypertensive patients and their families to improve their knowledge attitudes and behaviors toward treatment and control of their diseases. Education of health professionals toward the importance of pharmacological and non-pharmacological treatments of hypertension was another objective.

Conclusion
==========

In general the activities of this community trial helped in improving hypertension prevalence, awareness, treatment and control which may lead to decrease in cardiovascular complications in the future. Iran has one of the youngest populations worldwide; therefore we need more efforts to prevent hypertension from early life to improve the control rate of hypertension in young people in order to reduce burden of cardiovascular events in the future. The findings of this large sample size, quality controlled and comprehensive integrated interventions of IHHP can be generalized to other developing countries; however further steps need to be taken to evaluate the effects of these interventional activities on late-onset complications of hypertension.
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